Published January 1, 2021
| Version v1
Journal article
Open
Handling drug-target selectivity: A study on ureido containing Carbonic Anhydrase inhibitors
Creators
- 1. Ege Univ, Fac Pharm, Dept Pharmaceut Chem, TR-35100 Izmir, Turkey
- 2. Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA
- 3. Univ Firenze, NEUROFARBA Dept, Sez Sci Farmaceut & Nutraceut, Via Ugo Schiff 6, I-50019 Florence, Italy
Description
Here we report the synthesis of a series of taurine substituted sulfonamide derivatives 1-29 having the ureido moiety installed at the tail section as selective inhibitors of the tumor associated human (h) Carbonic Anhydrase (CA; EC 4.2.1.1) IX and XII. The series was deeply investigated for their kinetic features which demonstrated a strong dependence on the ureido moiety. High resolution X-ray crystallographic investigation on selected ligand adducts complexed with hCA II and hCA IX-mimic revealed a strong correlation between the ureido moiety and the amino acid residues Q92 and Q67 in both the hCA II and hCA IX-mimic, contributing to highly stabilized ligand-protein complex. (C) 2020 Elsevier Masson SAS. All rights reserved.
Files
bib-aecf61c5-722c-498e-958e-db52e3df11e7.txt
Files
(250 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:1aaecbb4ed4654e015e6b9641421e478
|
250 Bytes | Preview Download |